These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge. Malherbe DC; Mendy J; Vang L; Barnette PT; Reed J; Lakhashe SK; Owuor J; Gach JS; Legasse AW; Axthelm MK; LaBranche CC; Montefiori D; Forthal DN; Park B; Wilson JM; McLinden JH; Xiang J; Stapleton JT; Sacha JB; Haynes BF; Liao HX; Ruprecht RM; Smith J; Gurwith M; Haigwood NL; Alexander J J Virol; 2018 Jan; 92(2):. PubMed ID: 29093095 [TBL] [Abstract][Full Text] [Related]
3. Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251. Shacklett BL; Shaw KE; Adamson LA; Wilkens DT; Cox CA; Montefiori DC; Gardner MB; Sonigo P; Luciw PA J Virol; 2002 Nov; 76(22):11365-78. PubMed ID: 12388697 [TBL] [Abstract][Full Text] [Related]
4. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model. Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888 [TBL] [Abstract][Full Text] [Related]
5. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses. Abel K; Compton L; Rourke T; Montefiori D; Lu D; Rothaeusler K; Fritts L; Bost K; Miller CJ J Virol; 2003 Mar; 77(5):3099-118. PubMed ID: 12584336 [TBL] [Abstract][Full Text] [Related]
6. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques. Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899 [TBL] [Abstract][Full Text] [Related]
7. Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen. Zhao J; Pinczewski J; Gómez-Román VR; Venzon D; Kalyanaraman VS; Markham PD; Aldrich K; Moake M; Montefiori DC; Lou Y; Pavlakis GN; Robert-Guroff M J Virol; 2003 Aug; 77(15):8354-65. PubMed ID: 12857905 [TBL] [Abstract][Full Text] [Related]
8. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS. Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236 [TBL] [Abstract][Full Text] [Related]
9. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239. Horton H; Vogel TU; Carter DK; Vielhuber K; Fuller DH; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Montefiori DC; Erfle V; Desrosiers RC; Wilson N; Picker LJ; Wolinsky SM; Wang C; Allison DB; Watkins DI J Virol; 2002 Jul; 76(14):7187-202. PubMed ID: 12072518 [TBL] [Abstract][Full Text] [Related]
10. Vaccination with Live Attenuated Simian Immunodeficiency Virus (SIV) Protects from Mucosal, but Not Necessarily Intravenous, Challenge with a Minimally Heterologous SIV. Sutton MS; Burns CM; Weiler AM; Balgeman AJ; Braasch A; Lehrer-Brey G; Friedrich TC; O'Connor SL J Virol; 2016 Jun; 90(12):5541-5548. PubMed ID: 26962218 [TBL] [Abstract][Full Text] [Related]
11. Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies. Mascola JR; Lewis MG; VanCott TC; Stiegler G; Katinger H; Seaman M; Beaudry K; Barouch DH; Korioth-Schmitz B; Krivulka G; Sambor A; Welcher B; Douek DC; Montefiori DC; Shiver JW; Poignard P; Burton DR; Letvin NL J Virol; 2003 Oct; 77(19):10348-56. PubMed ID: 12970419 [TBL] [Abstract][Full Text] [Related]
12. Immunization with recombinant macaque major histocompatibility complex class I and II and human immunodeficiency virus gp140 inhibits simian-human immunodeficiency virus infection in macaques. Yang GB; Wang Y; Babaahmady K; Schøller J; Rahman D; Bunnik E; Spallek R; Zong CM; Duan JZ; Qin C; Jiang H; Singh M; Vaughan R; Bergmeier LA; Schuitemaker H; Shao Y; Lehner T J Gen Virol; 2012 Jul; 93(Pt 7):1506-1518. PubMed ID: 22492918 [TBL] [Abstract][Full Text] [Related]